Nuvectis Pharma, Inc. (NVCT) Free Cash Flow
Nuvectis Pharma, Inc. (NVCT) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2022-12-31 | -$13.56M |
| 2023-12-31 | -$15.95M |
| 2024-12-31 | -$12.25M |
| 2025-12-31 | -$16.01M |
How NVCT compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| NERV | — | -$13.50M |
| HSDT | Helius Medical Technologies Inc. | -$16.51M |
| RFL | Rafael Holdings Inc. Class B | -$18.95M |
| STIM | Neuronetics Inc. | -$21.18M |
| NEO | NeoGenomics Inc. | -$21.78M |
These are five companies in the same sector as NVCT with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Nuvectis Pharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("NVCT", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NVCT | $25.00 | -3.44% | 0.36M |
| 3 | ||||
| 4 | ||||
| 5 |